Funding Opportunities

• HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
  (PA-17-278)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard AIDS datess apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)
  (PA-17-279)
  National Institute of Allergy and Infectious Diseases
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
  (PA-17-280)
  National Institute of Allergy and Infectious Diseases
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  Application Receipt Date(s): Standard AIDS dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates .
• In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
  (PA-17-281)
  National Institute of Allergy and Infectious Diseases
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
  (PA-17-282)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
  (PA-17-283)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates .
• Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21)
  (PA-17-284)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01)
  (PA-17-285)
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Administrative Supplements for Participation in the Concept to Clinic: Commercializing Innovation (C3i) Program (Admin Supp)
  (PA-17-286)
  National Institute of Biomedical Imaging and Bioengineering
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Heart, Lung, and Blood Institute
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Genomic Community Resources (U24)
  (PAR-17-273)
  National Human Genome Research Institute
  National Cancer Institute
  Application Receipt Date(s): The first due date is July 13, 2017; Standard dates apply after that, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U01)
  (PAR-17-274)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 11, 2017 and then Standard dates apply by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44)
  (PAR-17-275)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. This FOA is being issued with limited due dates to accommodate the transition from FORMS-D to FORMS-E application packages. This FOA will be reissued for additional due date(s) on or after January 25, 2018.
• NIH StrokeNet Regional Coordinating Stroke Centers (U24)
  (PAR-17-276)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 25, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention Infrastructure Resource Access (X01)
  (PAR-17-277)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Applications are accepted by continuous receipt. Council Round Receipt Window January June 11 October 10 May October 11 February 10 October February 10 June 10 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Uncovering the Causes, Contexts, and Consequences of Elder Mistreatment (R01)
  (RFA-AG-18-010)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R01)
  (RFA-DA-18-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Exploring Novel RNA Modifications in HIV/AIDS and Substance Use Disorders (R21)
  (RFA-DA-18-009)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 17, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
• Wearable to Track Recovery and Relapse Factors for People w/ Addiction(R43/R44)
  (RFA-DA-18-010)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 15, 2017 , by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• National Laboratory Curriculum Framework Development (U18)
  (RFA-FD-17-012)
  Food and Drug Administration
  Application Receipt Date(s): July 10 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (PRECluDE) (U01)
  (RFA-HL-18-007)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): August 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science (R01)
  (RFA-OD-17-007)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science Small Grant Program for New Investigators (R03)
  (RFA-OD-17-008)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Office of Disease Prevention
  Application Receipt Date(s): August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science (R21)
  (RFA-OD-17-009)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Office of Disease Prevention
  Application Receipt Date(s): August 17, 2017, February 13, 2018, July 17, 2018, February 13, 2019), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.